Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13014752 | 0.87 | — | — | |
| SCHEMBL13014756 | 0.85 | — | — | |
| SCHEMBL13014749 | 0.85 | — | — | |
| SCHEMBL13014746 | 0.85 | — | — | |
| SCHEMBL2274832 | 0.84 | — | — | |
| SCHEMBL13014745 | 0.84 | — | — | |
| SCHEMBL13014742 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL2271152 | 0.84 | — | — | |
| SCHEMBL13014765 | 0.84 | MEN1 (0.53) | — | |
| SCHEMBL13014773 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170057932-A1 | BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | ROCHE PALO ALTO LLC (US) | 2017-03-02 | — | — | US | disclosed |
| US-9505726-B2 | Substituted biphenyl amides as P2X3 and P2X2/3 antagonists | ROCHE PALO ALTO LLC (US) | 2016-11-29 | — | — | US | disclosed |
| US-20150080408-A1 | PYRIDINYL AMIDES AS P2X3 AND P2X2/3 INHIBITORS | ROCHE PALO ALTO LLC (US) | 2015-03-19 | — | — | US | disclosed |
| US-8895589-B2 | Pyridinyl amides as P2X3 and P2X2/3 inhibitors | ROCHE PALO ALTO LLC (US) | 2014-11-25 | — | — | US | disclosed |
| US-20130165443-A1 | BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | BROKA CHRIS ALLEN (US) | 2013-06-27 | — | — | US | disclosed |
| US-8283383-B2 | Biphenyl amides as P2X3 and P2X2/3 antagonists | ROCHE PALO ALTO LLC (US) | 2012-10-09 | — | — | US | disclosed |
| US-8283383-B2 | Biphenyl amides as P2X3 and P2X2/3 antagonists | ROCHE PALO ALTO LLC (US) | 2012-10-09 | — | — | US | disclosed |
| WO-2010149578-A2 | NOVEL BIPHENYL AND PHENYL-PYRIDINE AMIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-12-29 | — | — | WO | disclosed |
| US-20100324056-A1 | BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | BROKA CHRIS ALLEN | 2010-12-23 | — | — | US | disclosed |
| US-20100324056-A1 | BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | BROKA CHRIS ALLEN | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080408-A1 | PYRIDINYL AMIDES AS P2X3 AND P2X2/3 INHIBITORS | P2RX3, P2RX2, P2RX1 | FABP1 3726/4885P2RY14 16/4885 |
| US-20100324056-A1 | BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | P2RX3, P2RX2, P2RX7 | FABP1 2320/4885P2RY14 17/4885 |
| US-20170057932-A1 | BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | P2RX3, P2RX2, P2RX7 | FABP1 2320/4885P2RY14 17/4885 |
| US-20130165443-A1 | BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | P2RX3, P2RX2, P2RX7 | FABP1 2320/4885P2RY14 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.